Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FEYZX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,189
Award facts
- Contract value 100% obligated
- $6,188.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,188.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pen injectors on July 28, 2025, with completion expected by July 29, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that supports comprehensive pharmaceutical and medical supply needs across the Defense Health System. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains significant pharmaceutical distribution operations.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. Zepbound, a semaglutide-based medication used for weight management, represents part of the company's broader pharmaceutical support for Defense Health Agency beneficiaries and other federal healthcare customers. AmerisourceBergen's SPE2DX master contract enables flexible, on-demand ordering of pharmaceutical products across multiple therapeutic domains, allowing the Defense Logistics Agency to efficiently procure medications for military personnel and beneficiaries worldwide.
Quick answers
Who was awarded contract SPE2DB25FEYZX?
SPE2DB25FEYZX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FEYZX worth?
The government has obligated $6,189 on SPE2DB25FEYZX.
Is contract SPE2DB25FEYZX an order under another contract?
Yes. SPE2DB25FEYZX is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FEYZX competed?
The extent of competition for SPE2DB25FEYZX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award